Invention Publication
- Patent Title: ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS
-
Application No.: US18351674Application Date: 2023-07-13
-
Publication No.: US20240011049A1Publication Date: 2024-01-11
- Inventor: J. Keith Joung , Peter Cabeceiras
- Applicant: The General Hospital Corporation , President and Fellows of Harvard College
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation,President and Fellows of Harvard College
- Current Assignee: The General Hospital Corporation,President and Fellows of Harvard College
- Current Assignee Address: US MA Boston
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C07K14/005

Abstract:
Human-derived virus-like particles (heVLPs), comprising a membrane comprising a phospholipid bilayer with one or more HERV-derived envelope proteins on the external side; one or more HERV-derived GAG proteins in the heVLP core, and a cargo molecule, e.g., a biomolecule and/or chemical cargo molecule, disposed in the core of the heVLP on the inside of the membrane, wherein the heVLP does not comprise a gag protein, except for gag proteins that are encoded in the human genome or gag proteins that are encoded by a consensus sequence that is derived from gag proteins found in the human genome, and methods of use thereof for delivery of the cargo molecule to cells.
Information query
IPC分类: